课题基金 / 基金详情

EXPERIMENTAL TRANSMISSION OF HTLV I TO NON HUMAN PRIMATE: SIV

EXPERIMENTAL TRANSMISSION OF HTLV I TO NON HUMAN PRIMATE: SIV
HTLV I 向非人类灵长类动物的实验传播:SIV
批准号:
6277450
负责人:
MARK A BEILKE
金额:
$8.66万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 1999-04-30

项目摘要

项目成果

MARK A BEILKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This collaborative project has established an animal model of HTLV-I associated disease in non-human primates with a primary HTLV-I viral isolate, derived from a human patient with HTLV-I associated tropical spastic paraparesis (TSP). Two of three inoculated rhesus macaques were infected and showed signs of disease. One animal presented with a findings identical to that in the original patient, with muscle atrophy, polymyositis, and arthritis . The second animal was dually infected with SIV and developed signs suggestive of smoldering HTLV-I induced leukemia in the presence of SIV immunodeficiency disease. This work is published. Five additional animals were inoculated with this same HTLV-I isolate. Four of five had persistent viral antigen detection in the peripheral circulation associated with weak humoral responses, while the fifth animal was persistently antigen negative associated with a strong humoral response. These results suggest that immune responses are important in controlling HTLV-I virus expression in the macaque model. This work was presented at a national conference and the abstract published. We are currently in the process of developing autologous transformed cell lines from each of the animals as well as and vaccinia-HTLV-I virus constructs to characterize the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
Immunomodulatory Function of Human T Cell Leukemia Virus Type 2 (HTLV-2)
HIV, HTLV AND DRUG ABUSE
  • 批准号:
    7716239
  • 项目类别:
  • 资助金额:
    $6.33万
  • 财政年份:
    2008
  • 负责人:
    MARK A BEILKE
  • 依托单位:
海外基金